v3.25.1
Consolidated Statements of Comprehensive Income (loss) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Consolidated Statements of Comprehensive Income Loss [Abstract]      
Revenue $ 9,094 $ 7,633 $ 7,264
Cost of revenue 5,290 4,464 4,836
Gross profit 3,804 3,169 2,428
Research and development expenses 577 1,048 439
Selling and marketing expenses 1,367 3,170 672
General and administrative expenses 3,325 1,732 837
Other expenses 5
Operating profit (loss) (1,470) (2,781) 480
Listing expenses 879
Finance expenses 124 104 123
Finance income (127) (67) (1,443)
Income (loss) before income tax (2,346) (2,818) 1,800
Income tax expenses 1 1 2
Net income (loss) (2,347) (2,819) 1,798
Amounts that shall not be subsequently reclassified to profit and loss:      
Gain from remeasurement of defined benefit plans 3 6 16
Total comprehensive income (loss) attributed to the shareholders of the Company $ (2,344) $ (2,813) $ 1,814
Basic earnings (loss) per share (in $) (in Dollars per share) $ (0.4505) $ (0.8916) $ 0.568
Weighted average of the number of ordinary shares used to calculate basic earnings per share (in Shares) 5,210,317 3,161,779 3,161,779
Diluted earnings (loss) per share (in $) (in Dollars per share) $ (0.4505) $ (0.8916) $ 0.542
Weighted average of the number of ordinary shares used to calculate diluted earnings per share (in Shares) 5,210,317 3,161,779 3,317,185